Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Aspira Women’s Health ( (AWHL) ) just unveiled an update.
On September 2, 2025, Aspira Women’s Health appointed Brian Hungerford as its Chief Financial Officer and Principal Accounting Officer, replacing Julie Carrillo. Hungerford, with over 20 years of experience, previously served as CFO for Kiromic Biopharma, Inc. His compensation package includes a $300,000 annual salary, a potential 35% cash bonus, and stock options. The Consulting Agreement outlines terms for salary continuation and stock option vesting in the event of termination without cause or following a change of control.
The most recent analyst rating on (AWHL) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Aspira Women’s Health stock, see the AWHL Stock Forecast page.
Spark’s Take on AWHL Stock
According to Spark, TipRanks’ AI Analyst, AWHL is a Neutral.
The company’s challenging financial position, marked by unprofitability and negative equity, significantly impacts its stock score. While technical indicators show some positive momentum, the lack of profitability and adverse corporate events weigh heavily on the overall assessment.
To see Spark’s full report on AWHL stock, click here.
More about Aspira Women’s Health
Average Trading Volume: 117,088
Technical Sentiment Signal: Sell
Current Market Cap: $14.77M
See more data about AWHL stock on TipRanks’ Stock Analysis page.